SEOUL, July 10, 2026 SK hynix is not bringing a startup story to Nasdaq. It is bringing the core memory supplier in the AI server buildout, and the terms landed at a scale that forces attention. In its final prospectus, the South Korean chipmaker priced 177.9 million ADSs at $149, raising about $26.5 billion and setting up what the Associated Press described as the biggest initial U.S. share sale by a foreign company.
The demand color is what gives the launch more shape than a plain record-book headline. In the July 6 amended F-1, SK hynix disclosed indications of interest for up to $7 billion from Baillie Gifford Overseas, Coatue-managed funds, and Situational Awareness Partners. By the time books closed, a Reuters report carried by KFGO said demand ran at more than seven times the shares on offer. IPOGrid reads that combination as more important than the record itself: named long-only and tech crossover demand gave the deal an institutional spine before the broader frenzy showed up.
The underwriting roster also tells a story. SK hynix's June 30 amendment listed only BofA Securities, Citigroup, Goldman Sachs and J.P. Morgan. By the July 6 filing and the priced prospectus, the syndicate had widened to 13 firms, including Cantor, Mizuho, Needham, RBC, Rosenblatt, Stifel, Wedbush, William Blair and Wolfe | Nomura Alliance. Our interpretation is that this looks like a distribution decision as much as a prestige lineup. For a deal this large, broad placement mattered.
The operating backdrop is unusually strong for an issuer coming to the U.S. market. In its FY2025 results release, SK hynix reported revenue of 97.1467 trillion won, operating profit of 47.2063 trillion won and net profit of 42.9479 trillion won, all records for the company. The same release tied that performance to HBM and other high value memory products, while the AP report noted that the U.S. accounted for 68.8% of 2025 revenue. This is why the ADR matters today: U.S. investors are getting direct access to one of the clearest public equity expressions of AI infrastructure demand, not a proxy two steps removed.
There is also a strategic U.S. buildout behind the listing. SK hynix said in January that it would form a U.S. arm focused on AI solutions, and in the same month said construction of advanced packaging facilities in Indiana and Cheongju was progressing. The AP dispatch also pointed to Indiana as the site of its first U.S. production facility. IPOGrid would frame the ADR as a financing event, but also as a geopolitical and customer-proximity event. SK hynix is putting more of its capital-markets and manufacturing footprint closer to its largest end market.
That said, the caution flag is easy to see. The same Reuters report said the stock had already fallen about a quarter in the prior two weeks even after an extraordinary 12-month run, a reminder that memory cycles still punish late enthusiasm. Reuters also highlighted the valuation argument behind the ADR, citing a forward earnings multiple below Micron's. The reviewer's concern is that U.S. buyers are being invited into a premium narrative at the point when the company is already the market's preferred AI memory winner. That can still work, but it is different from discovering an underfollowed issuer.
The use of proceeds keeps the mandate broad. The final prospectus says the money is for general corporate purposes, including working capital and potential acquisitions, and it states the ADSs have been approved for listing on Nasdaq under SKHY with settlement expected on July 14. That flexibility makes sense for a company funding fabs, packaging capacity and optional strategic moves, but it also means public investors are underwriting balance-sheet firepower rather than a tightly ring-fenced project.
The bottom line is straightforward. SK hynix deserves the spotlight because it has turned the AI memory shortage into a U.S. market event with rare scale, named demand and real earnings behind it. The bullish case is easy to understand. Our read is that the more interesting question is whether Nasdaq gives SK hynix a lasting valuation reset, or merely a brief U.S. premium on top of a cycle that already looks very well understood.